000 01285 a2200385 4500
005 20250514035641.0
264 0 _c20020910
008 200209s 0 0 eng d
022 _a0300-0664
024 7 _a10.1046/j.1365-2265.2002.01559.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMcCallum, Roland W
245 0 0 _aGrowth hormone deficiency and vascular risk.
_h[electronic resource]
260 _bClinical endocrinology
_cJul 2002
300 _a11-24 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdult
650 0 4 _aCardiovascular Diseases
_xetiology
650 0 4 _aEndothelium, Vascular
_xphysiopathology
650 0 4 _aHemostasis
650 0 4 _aHuman Growth Hormone
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aHypertension
_xcomplications
650 0 4 _aPituitary Diseases
_xcomplications
650 0 4 _aPrevalence
650 0 4 _aRisk
650 0 4 _aSomatostatin
_xdeficiency
650 0 4 _aUnited Kingdom
650 0 4 _aVascular Resistance
700 1 _aPetrie, John R
700 1 _aDominiczak, Anna F
700 1 _aConnell, John M C
773 0 _tClinical endocrinology
_gvol. 57
_gno. 1
_gp. 11-24
856 4 0 _uhttps://doi.org/10.1046/j.1365-2265.2002.01559.x
_zAvailable from publisher's website
999 _c11993787
_d11993787